Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong
| Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong |
| Edizione | [7th ed.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley-Blackwell, , 2024 |
| Descrizione fisica | 1 online resource (502 pages) |
| Disciplina | 618.3 |
| Soggetto topico |
Pregnancy Complications
Pregnancy, High-Risk Evidence-Based Medicine - methods |
| ISBN |
1-119-63654-X
1-119-63653-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Preface -- Acknowledgments -- Part 1 Factors of High-Risk Pregnancy -- Chapter 1 Overview of High-Risk Pregnancy -- Chapter 2 Nutrition in Pregnancy -- Fetal growth -- Body mass index, weight gain, and adverse pregnancy outcomes -- Obesity -- Nutrition assessment and counseling -- Food security -- Energy intake during pregnancy -- Healthy dietary pattern in pregnancy -- Multivitamins -- Micronutrients in pregnancy -- Iron -- Folate/folic acid -- Calcium -- Vitamin D -- Iodine -- Vitamin toxicity -- Caffeine consumption in pregnancy -- Seafood consumption in pregnancy -- Multifetal pregnancy -- Nutrition during lactation -- Conclusion -- References -- Chapter 3 Alcohol and Substance Use Disorder -- Introduction -- Screening and testing for substance use disorder -- Alcohol -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Opioids -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Intrapartum and postpartum care -- Cannabis -- Stimulants -- Vaping (E-cigarettes) -- Benzodiazepines -- References -- Chapter 4 Environmental Agents and Reproductive Risk -- Background incidence of adverse outcome -- Biologic evidence of toxicity -- General principles -- Specific agents -- Lead -- Mercury -- Pesticides and herbicides -- Polychlorinated biphenyls -- Polybrominated diphenyl ethers -- Organic solvents -- Perfluorochemicals -- Video display terminals -- Bisphenol A -- Phthalates -- Air pollutants -- References -- Part 2 Genetics -- Chapter 5 Genetic Screening for Mendelian Disorders -- Family history -- Mendelian inheritance -- Carrier screening -- Carrier screening guidelines -- Hemoglobinopathies -- Cystic fibrosis -- Spinal muscular atrophy -- Fragile X syndrome -- Jewish genetic diseases -- Prenatal diagnosis -- Newborn screening.
References -- Chapter 6 Screening for Congenital Heart Disease -- Introduction -- Screening low-risk populations -- Benefits of cardiac screening -- High-risk populations for fetal echocardiography -- Normal fetal heart anatomy -- Technique -- Two-dimensional cross-sectional imaging -- Four-chamber view -- Ventricular outflow tracts -- Three-vessel and three-vessel trachea views -- Additional cardiac views -- Color Doppler imaging -- Expectations from cardiac screening -- Four-chamber view -- Addition of outflow tract views and three-vessel views -- Conclusion -- References -- Chapter 7 First- and Second-Trimester Screening for Fetal Aneuploidy and Neural Tube Defects -- First-trimester sonographic screening -- Combined first-trimester serum and sonographic screening -- First-trimester cystic hygroma -- Second-trimester sonographic screening -- Second-trimester serum screening -- Combined first- and second-trimester screening -- Screening in multiple gestations -- Screening for neural tube defects -- Cell-free fetal DNA (cffDNA) screening for fetal aneuploidy -- Scientific basis of cffDNA screening -- Limitations of cffDNA screening -- CffDNA screening performance -- Implementation of cffDNA testing in clinical practice -- References -- Part 3 Fetal Assessment -- Chapter 8 Sonographic Dating and Standard Fetal Biometry -- Pregnancy dating -- First trimester -- Second and third trimesters -- Estimation of fetal weight -- Macrosomia -- Fetal growth restriction -- Definition -- Symmetric versus asymmetric -- Timing of diagnosis -- Risk factors -- Outcome -- Management -- Fetal arterial Doppler -- Venous Doppler and fetal growth restriction -- Clinical application -- References -- Chapter 9 Antepartum Fetal Monitoring -- Nonstress test -- Biophysical profile -- Modified biophysical profile (NST/amniotic fluid volume) -- Doppler velocimetry -- References. Chapter 10 Interpreting Intrapartum Fetal Heart Tracings -- Components of EFM documentation -- Baseline FHR -- Baseline FHR variability -- Accelerations -- Decelerations -- Uterine contractions -- Changes and trends in FHR over time -- Interpretation of EFM -- Category I -- Category III -- Category II -- Management of FHR abnormalities in labor -- Placement of internal monitors (intrauterine pressure catheter, fetal scalp electrode) -- Tachysystole with fetal heart rate changes -- Maternal hypotension -- Maternal repositioning -- Intravenous fluid bolus -- Maternal hyperoxygenation -- Amnioinfusion -- Fetal stimulation -- Future directions -- References -- Part 4 Maternal Disease -- Chapter 11 Sickle Cell Anemia -- Hemoglobin SCD -- Hemoglobin S/-thalassemia disease -- Management during pregnancy -- Acute pain -- Chronic pain -- Prophylactic red blood cell transfusions -- Other treatments -- Fetal assessment -- Labor and delivery -- Genetic evaluation -- CASE PRESENTATION -- References -- Chapter 12 Anemia -- Consequences -- Causes of anemia in pregnancy -- Diagnostic workup and treatment -- Macrocytic anemia -- Normocytic anemia -- Microcytic anemia -- Iron supplementation in pregnancy -- Treatment of iron deficiency anemia -- References -- Chapter 13 Thrombocytopenia -- Maternal thrombocytopenia -- Gestational thrombocytopenia -- Autoimmune thrombocytopenia -- HELLP -- Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome -- Other causes -- Fetal thrombocytopenia -- Autoimmune thrombocytopenia -- Alloimmune thrombocytopenia -- References -- Chapter 14 Inherited and Acquired Thrombophilias -- Overview of hemostasis changes during pregnancy -- Inherited thrombophilias -- Factor V Leiden -- Prothrombin gene mutation (G2021A) -- Protein C deficiency -- Protein S deficiency -- Antithrombin deficiency -- Acquired thrombophilia. Antiphospholipid antibody syndrome -- Management considerations in patients with inherited or acquired thrombophilia -- Inherited thrombophilia -- Antiphospholipid antibody syndrome -- Summary -- References -- Chapter 15 Thromboembolic Disorders -- Physiology of hemostasis -- Platelet plug formation -- The coagulation cascade -- Endogenous anticoagulants -- Pathophysiology of and risk factors for thrombosis in pregnancy -- Diagnosis of venous thromboembolism -- Deep venous thrombosis -- Pulmonary embolus -- Conclusion -- References -- Chapter 16 Cardiac Disease in Pregnancy -- Risk assessment and risk-appropriate care -- Antenatal care and optimization -- First trimester -- Second trimester -- Third trimester -- Multidisciplinary delivery planning -- Mode of delivery -- Analgesia and anesthesia -- Monitoring and emergency preparedness -- Postpartum and interconception care -- Conclusion -- References -- Chapter 17 Renal Disease -- Physiological changes in renal function during pregnancy -- Anatomic changes in the urinary tract during pregnancy -- Renal disease in pregnancy -- Proteinuria -- Chronic kidney disease -- Mild renal insufficiency -- Moderate and severe renal insufficiency -- Hypertensive disorders with renal insufficiency -- Renal dialysis -- Renal transplantation -- Management of pregnancies complicated by renal disease -- Conclusion -- References -- Chapter 18 Pregnancy in Transplant Patients -- Prepregnancy assessment and counseling -- Antepartum care -- Review of common agents for maintenance immunosuppression -- Kidney transplant -- Other organ transplant patients -- Kidney-pancreas -- Liver -- Heart -- Lung -- Other transplant groups -- Uterus -- Intrapartum management -- Obstetric emergencies -- The baby -- References -- Chapter 19 Gestational Diabetes Mellitus -- Risk factors for gestational diabetes. Therapeutic modalities in gestational diabetes -- Antenatal testing -- Delivery: when and how to deliver -- Postpartum considerations -- References -- Chapter 20 Diabetes Mellitus -- Initial evaluation -- Regulating maternal glycemia -- Management during pregnancy -- Management of insulin during labor -- References -- Chapter 21 Thyroid Disorders -- Diagnosis -- Additional studies -- Hypothyroidism -- Implications for pregnancy -- Treatment -- Hyperthyroidism -- Implications for pregnancy -- Management -- Thyroid storm management [3,4,10] -- References -- Chapter 22 Asthma -- Definition of asthma -- Effect of pregnancy on the course of asthma -- Clinical observations -- Mechanisms -- Effect of asthma on pregnancy -- Clinical observations -- Mechanisms -- Diagnosis of asthma during pregnancy -- Management -- Assessment and monitoring -- Control of factors contributing to severity -- Patient education -- Pharmacologic therapy -- Chronic asthma -- Acute asthma -- Management during labor and delivery -- Conclusion -- References -- Chapter 23 Epilepsy -- Contraception -- Fertility -- Preconception counseling -- Folic acid -- Seizures during pregnancy -- ASM risks: Structural and neurodevelopmental teratogenicity -- Management during pregnancy -- Prenatal screening -- ASM levels -- Peripartum care -- Labor and delivery -- Maternal outcomes -- Postpartum care -- ASM management and seizure risk -- Breastfeeding -- Postpartum depression -- Summary -- References -- Chapter 24 Chronic Hypertension -- Definition -- Diagnosis -- Preconceptional counseling -- Morbidity and mortality -- Diagnosis and evaluation in pregnancy -- Treatment during pregnancy -- Antepartum fetal assessment -- Delivery -- Postpartum care -- References -- Chapter 25 Systemic Lupus Erythematosus -- Epidemiology -- Etiology -- Pathogenesis -- Differential diagnosis -- Morbidity. General morbidity and mortality. |
| Altri titoli varianti | Management of high-risk pregnancy |
| Record Nr. | UNINA-9910830543503321 |
| Hoboken, NJ : , : Wiley-Blackwell, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong
| Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong |
| Edizione | [7th ed.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley-Blackwell, , 2024 |
| Descrizione fisica | 1 online resource (502 pages) |
| Disciplina | 618.3 |
| Soggetto topico |
Pregnancy Complications
Pregnancy, High-Risk Evidence-Based Medicine - methods |
| ISBN |
1-119-63654-X
1-119-63653-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Preface -- Acknowledgments -- Part 1 Factors of High-Risk Pregnancy -- Chapter 1 Overview of High-Risk Pregnancy -- Chapter 2 Nutrition in Pregnancy -- Fetal growth -- Body mass index, weight gain, and adverse pregnancy outcomes -- Obesity -- Nutrition assessment and counseling -- Food security -- Energy intake during pregnancy -- Healthy dietary pattern in pregnancy -- Multivitamins -- Micronutrients in pregnancy -- Iron -- Folate/folic acid -- Calcium -- Vitamin D -- Iodine -- Vitamin toxicity -- Caffeine consumption in pregnancy -- Seafood consumption in pregnancy -- Multifetal pregnancy -- Nutrition during lactation -- Conclusion -- References -- Chapter 3 Alcohol and Substance Use Disorder -- Introduction -- Screening and testing for substance use disorder -- Alcohol -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Opioids -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Intrapartum and postpartum care -- Cannabis -- Stimulants -- Vaping (E-cigarettes) -- Benzodiazepines -- References -- Chapter 4 Environmental Agents and Reproductive Risk -- Background incidence of adverse outcome -- Biologic evidence of toxicity -- General principles -- Specific agents -- Lead -- Mercury -- Pesticides and herbicides -- Polychlorinated biphenyls -- Polybrominated diphenyl ethers -- Organic solvents -- Perfluorochemicals -- Video display terminals -- Bisphenol A -- Phthalates -- Air pollutants -- References -- Part 2 Genetics -- Chapter 5 Genetic Screening for Mendelian Disorders -- Family history -- Mendelian inheritance -- Carrier screening -- Carrier screening guidelines -- Hemoglobinopathies -- Cystic fibrosis -- Spinal muscular atrophy -- Fragile X syndrome -- Jewish genetic diseases -- Prenatal diagnosis -- Newborn screening.
References -- Chapter 6 Screening for Congenital Heart Disease -- Introduction -- Screening low-risk populations -- Benefits of cardiac screening -- High-risk populations for fetal echocardiography -- Normal fetal heart anatomy -- Technique -- Two-dimensional cross-sectional imaging -- Four-chamber view -- Ventricular outflow tracts -- Three-vessel and three-vessel trachea views -- Additional cardiac views -- Color Doppler imaging -- Expectations from cardiac screening -- Four-chamber view -- Addition of outflow tract views and three-vessel views -- Conclusion -- References -- Chapter 7 First- and Second-Trimester Screening for Fetal Aneuploidy and Neural Tube Defects -- First-trimester sonographic screening -- Combined first-trimester serum and sonographic screening -- First-trimester cystic hygroma -- Second-trimester sonographic screening -- Second-trimester serum screening -- Combined first- and second-trimester screening -- Screening in multiple gestations -- Screening for neural tube defects -- Cell-free fetal DNA (cffDNA) screening for fetal aneuploidy -- Scientific basis of cffDNA screening -- Limitations of cffDNA screening -- CffDNA screening performance -- Implementation of cffDNA testing in clinical practice -- References -- Part 3 Fetal Assessment -- Chapter 8 Sonographic Dating and Standard Fetal Biometry -- Pregnancy dating -- First trimester -- Second and third trimesters -- Estimation of fetal weight -- Macrosomia -- Fetal growth restriction -- Definition -- Symmetric versus asymmetric -- Timing of diagnosis -- Risk factors -- Outcome -- Management -- Fetal arterial Doppler -- Venous Doppler and fetal growth restriction -- Clinical application -- References -- Chapter 9 Antepartum Fetal Monitoring -- Nonstress test -- Biophysical profile -- Modified biophysical profile (NST/amniotic fluid volume) -- Doppler velocimetry -- References. Chapter 10 Interpreting Intrapartum Fetal Heart Tracings -- Components of EFM documentation -- Baseline FHR -- Baseline FHR variability -- Accelerations -- Decelerations -- Uterine contractions -- Changes and trends in FHR over time -- Interpretation of EFM -- Category I -- Category III -- Category II -- Management of FHR abnormalities in labor -- Placement of internal monitors (intrauterine pressure catheter, fetal scalp electrode) -- Tachysystole with fetal heart rate changes -- Maternal hypotension -- Maternal repositioning -- Intravenous fluid bolus -- Maternal hyperoxygenation -- Amnioinfusion -- Fetal stimulation -- Future directions -- References -- Part 4 Maternal Disease -- Chapter 11 Sickle Cell Anemia -- Hemoglobin SCD -- Hemoglobin S/-thalassemia disease -- Management during pregnancy -- Acute pain -- Chronic pain -- Prophylactic red blood cell transfusions -- Other treatments -- Fetal assessment -- Labor and delivery -- Genetic evaluation -- CASE PRESENTATION -- References -- Chapter 12 Anemia -- Consequences -- Causes of anemia in pregnancy -- Diagnostic workup and treatment -- Macrocytic anemia -- Normocytic anemia -- Microcytic anemia -- Iron supplementation in pregnancy -- Treatment of iron deficiency anemia -- References -- Chapter 13 Thrombocytopenia -- Maternal thrombocytopenia -- Gestational thrombocytopenia -- Autoimmune thrombocytopenia -- HELLP -- Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome -- Other causes -- Fetal thrombocytopenia -- Autoimmune thrombocytopenia -- Alloimmune thrombocytopenia -- References -- Chapter 14 Inherited and Acquired Thrombophilias -- Overview of hemostasis changes during pregnancy -- Inherited thrombophilias -- Factor V Leiden -- Prothrombin gene mutation (G2021A) -- Protein C deficiency -- Protein S deficiency -- Antithrombin deficiency -- Acquired thrombophilia. Antiphospholipid antibody syndrome -- Management considerations in patients with inherited or acquired thrombophilia -- Inherited thrombophilia -- Antiphospholipid antibody syndrome -- Summary -- References -- Chapter 15 Thromboembolic Disorders -- Physiology of hemostasis -- Platelet plug formation -- The coagulation cascade -- Endogenous anticoagulants -- Pathophysiology of and risk factors for thrombosis in pregnancy -- Diagnosis of venous thromboembolism -- Deep venous thrombosis -- Pulmonary embolus -- Conclusion -- References -- Chapter 16 Cardiac Disease in Pregnancy -- Risk assessment and risk-appropriate care -- Antenatal care and optimization -- First trimester -- Second trimester -- Third trimester -- Multidisciplinary delivery planning -- Mode of delivery -- Analgesia and anesthesia -- Monitoring and emergency preparedness -- Postpartum and interconception care -- Conclusion -- References -- Chapter 17 Renal Disease -- Physiological changes in renal function during pregnancy -- Anatomic changes in the urinary tract during pregnancy -- Renal disease in pregnancy -- Proteinuria -- Chronic kidney disease -- Mild renal insufficiency -- Moderate and severe renal insufficiency -- Hypertensive disorders with renal insufficiency -- Renal dialysis -- Renal transplantation -- Management of pregnancies complicated by renal disease -- Conclusion -- References -- Chapter 18 Pregnancy in Transplant Patients -- Prepregnancy assessment and counseling -- Antepartum care -- Review of common agents for maintenance immunosuppression -- Kidney transplant -- Other organ transplant patients -- Kidney-pancreas -- Liver -- Heart -- Lung -- Other transplant groups -- Uterus -- Intrapartum management -- Obstetric emergencies -- The baby -- References -- Chapter 19 Gestational Diabetes Mellitus -- Risk factors for gestational diabetes. Therapeutic modalities in gestational diabetes -- Antenatal testing -- Delivery: when and how to deliver -- Postpartum considerations -- References -- Chapter 20 Diabetes Mellitus -- Initial evaluation -- Regulating maternal glycemia -- Management during pregnancy -- Management of insulin during labor -- References -- Chapter 21 Thyroid Disorders -- Diagnosis -- Additional studies -- Hypothyroidism -- Implications for pregnancy -- Treatment -- Hyperthyroidism -- Implications for pregnancy -- Management -- Thyroid storm management [3,4,10] -- References -- Chapter 22 Asthma -- Definition of asthma -- Effect of pregnancy on the course of asthma -- Clinical observations -- Mechanisms -- Effect of asthma on pregnancy -- Clinical observations -- Mechanisms -- Diagnosis of asthma during pregnancy -- Management -- Assessment and monitoring -- Control of factors contributing to severity -- Patient education -- Pharmacologic therapy -- Chronic asthma -- Acute asthma -- Management during labor and delivery -- Conclusion -- References -- Chapter 23 Epilepsy -- Contraception -- Fertility -- Preconception counseling -- Folic acid -- Seizures during pregnancy -- ASM risks: Structural and neurodevelopmental teratogenicity -- Management during pregnancy -- Prenatal screening -- ASM levels -- Peripartum care -- Labor and delivery -- Maternal outcomes -- Postpartum care -- ASM management and seizure risk -- Breastfeeding -- Postpartum depression -- Summary -- References -- Chapter 24 Chronic Hypertension -- Definition -- Diagnosis -- Preconceptional counseling -- Morbidity and mortality -- Diagnosis and evaluation in pregnancy -- Treatment during pregnancy -- Antepartum fetal assessment -- Delivery -- Postpartum care -- References -- Chapter 25 Systemic Lupus Erythematosus -- Epidemiology -- Etiology -- Pathogenesis -- Differential diagnosis -- Morbidity. General morbidity and mortality. |
| Altri titoli varianti | Management of high-risk pregnancy |
| Record Nr. | UNINA-9910841064203321 |
| Hoboken, NJ : , : Wiley-Blackwell, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by John T. Queenan, Catherine Y. Spong, Charles J. Lockwood
| Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by John T. Queenan, Catherine Y. Spong, Charles J. Lockwood |
| Edizione | [6th ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, : Wiley-Blackwell, 2012 |
| Descrizione fisica | 1 online resource (510 p.) |
| Disciplina | 618.3 |
| Altri autori (Persone) |
QueenanJohn T
SpongCatherine Y LockwoodCharles J |
| Soggetto topico |
Pregnancy - Complications
Obstetrical emergencies |
| ISBN |
1-119-96376-1
1-283-40977-1 9786613409775 1-119-96378-8 1-119-96375-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Queenan's Management of High-Risk Pregnancy: An Evidence-Based Approach, SIXTH EDITION; Contents; List of Contributors; Foreword; Preface; Acknowledgments; List of Abbreviations; Part 1: Factors of High-Risk Pregnancy; Chapter 1: Overview of High-Risk Pregnancy; Chapter 2: Maternal Nutrition; Chapter 3: Alcohol and Substance Abuse; Chapter 4: Environmental Agents and Reproductive Risk; Part 2: Genetics; Chapter 5: Genetic Screening for Mendelian Disorders; Chapter 6: Screening for Congenital Heart Disease
Chapter 7: First- and Second-Trimester Screening for Fetal Aneuploidy and Neural Tube DefectsPart 3: Monitoring: Biochemical and Biophysical; Chapter 8: Sonographic Dating and Standard Fetal Biometry; Chapter 9: Fetal Lung Maturity; Chapter 10: Antepartum Fetal Monitoring; Chapter 11: Interpreting Intrapartum Fetal Heart Tracings; Part 4: Maternal Disease; Chapter 12: Sickle Cell Anemia; Chapter 13: Anemia; Chapter 14: Thrombocytopenia; Chapter 15: Inherited and Acquired Thrombophilias; Chapter 16: Thromboembolic Disorders; Chapter 17: Cardiac Disease; Chapter 18: Renal Disease Chapter 19: Pregnancy in Transplant PatientsChapter 20: Gestational Diabetes Mellitus; Chapter 21: Diabetes Mellitus; Chapter 22: Hypothyroidism and Hyperthyroidism; Chapter 23: Asthma; Chapter 24: Epilepsy; Chapter 25: Chronic Hypertension; Chapter 26: Systemic Lupus Erythematosus; Chapter 27: Perinatal Infections; Chapter 28: Malaria; Chapter 29: Group B Streptococcal Infection; Chapter 30: Hepatitis; Chapter 31: HIV Infection; Chapter 32: Pregnancy in Women with Physical Disabilities; Part 5: Obstetric Complications; Chapter 33: Recurrent Spontaneous Abortion Chapter 34: Cervical InsufficiencyChapter 35: Gestational Hypertension, Preeclampsia, and Eclampsia; Chapter 36: Postpartum Hemorrhage; Chapter 37: Emergency Care; Chapter 38: Rh and Other Blood Group Alloimmunizations; Chapter 39: Multiple Gestations; Chapter 40: Polyhydramnios and Oligohydramnios; Chapter 41: Prevention of Preterm Birth; Chapter 42: Pathogenesis and Prediction of Preterm Delivery; Chapter 43: Preterm Premature Rupture of Membranes; Chapter 44: Management of Preterm Labor; Chapter 45: Placenta Previa and Related Placental Disorders Part 6: Complications of Labor and DeliveryChapter 46: Prolonged Pregnancy; Chapter 47: Induction of Labor; Chapter 48: Cesarean Delivery; Chapter 49: Vaginal Birth after Cesarean Delivery; Chapter 50: Breech Delivery; Chapter 51: Operative Vaginal Delivery; Chapter 52: Obstetric Analgesia and Anesthesia; Chapter 53: Patient Safety; Chapter 54: Neonatal Encephalopathy and Cerebral Palsy; Part 7 Procedures; Chapter 55: Genetic Amniocentesis and Chorionic Villus Sampling; Chapter 56: Fetal Surgery; Index; color plate |
| Altri titoli varianti | Management of high-risk pregnancy |
| Record Nr. | UNINA-9910141350403321 |
| Chichester, West Sussex, : Wiley-Blackwell, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Queenan’s management of high-risk pregnancy [Risorsa elettronica] : an evidence-based approach / edited by John T. Queenan, Catherine Y. Spong, Charles J. Lockwood
| Queenan’s management of high-risk pregnancy [Risorsa elettronica] : an evidence-based approach / edited by John T. Queenan, Catherine Y. Spong, Charles J. Lockwood |
| Edizione | [6th ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex : Wiley-Blackwell, 2012 |
| Disciplina | 618.3 |
| Soggetto non controllato | Gravidanza - Complicazioni |
| ISBN | 9781119963783 |
| Formato | Risorse elettroniche  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Management of high-risk pregnancy |
| Record Nr. | UNINA-990009807540403321 |
| Chichester, West Sussex : Wiley-Blackwell, 2012 | ||
| Risorse elettroniche | ||
| Lo trovi qui: Univ. Federico II | ||
| ||